MRO Acquires AI-Driven Clinical Trial Recruitment Platform Clinetic to Streamline Patient Enrollment
核心洞察
MRO (搜索) has acquired Clinetic (搜索), an AI-driven recruitment management platform that helps healthcare organizations and life sciences companies find, screen and enroll patients for clinical trials with greater speed and precision.
Clinetic (搜索)'s software integrates directly with electronic health record systems through secure connectors, enabling real-time access to comprehensive clinical data for more than 15 million patients across the US.
The acquisition aims to address recruitment challenges facing hospitals that want to participate in clinical studies but lack the necessary resources, technology or expertise to complete the enrollment process.
MRO (搜索) announced the acquisition of Clinetic (搜索), a leading recruitment management platform designed to help healthcare organizations and life sciences companies find, screen and enroll patients for clinical trials with greater speed and precision. The addition of Clinetic's AI-driven software and expertise marks another step forward in MRO's commitment to being the single source for smarter data—merging progressive technology and deep clinical expertise to advance patient care and healthcare innovation.
Addressing Clinical Trial Recruitment Challenges
"Partnering with more than 2,000 hospitals and health systems, we have seen first-hand the challenges facing hospitals that want to bring clinical studies to their patient population, but lack the resources, technology or expertise to complete the process," said Lidia Bernik, President of Curation Solutions. "By adding Clinetic (搜索) to our existing platform, we can start delivering a 'human-in-the-loop' solution at scale. This will translate to more efficient research at our sites and higher success for clinical research sponsors on a national level."
Advanced EHR Integration Technology
Clinetic (搜索)'s software integrates directly with provider electronic health record (EHR) systems by installing secure, behind-the-firewall connectors. This enables direct access to comprehensive historical and clinical data needed to meet the unique requirements of each clinical trial protocol. By tapping into this real-time data layer, research teams can efficiently identify eligible patients across a wide range of therapeutic areas, build more precise cohorts, and plan studies with greater confidence.
"Clinetic (搜索) has strong roots in healthcare, already evaluating the data of more than 15 million patients across the US," said Tom Kaminski, Clinetic CEO. "Joining MRO was a natural fit, considering our joint focus on transforming unstructured clinical data into actionable data sets and unwavering commitment to our hospital partners and the communities they serve."
Strategic Implementation Plans
MRO (搜索) plans to leverage this software across multiple aspects of its business. Primarily, for hospitals and health systems looking to grow their participation in clinical trials, the software will expand recruitment capacity and streamline patient enrollment. This will include members of the Q-Centrix Research Network (搜索), which is an MRO company.
By connecting providers and life sciences organizations, trial sponsors will benefit from faster patient recruitment, expanded provider access, and data of the highest quality. The integration represents what Bernik describes as "more than a technology upgrade" but rather "a meaningful shift in how research can be conducted."
Impact on Clinical Research Operations
"Reducing the manual work required to identify and enroll participants in trials enables clinical research staff and coordinators to focus on priorities that advance studies and improve patient outcomes," said Bernik. The acquisition positions MRO (搜索) to unlock greater value for life sciences partners through market-leading technology and clinical expertise.
MRO (搜索)'s innovative model for clinical data management combines FHIR-native connectivity, deep clinical expertise, and advanced automation to turn a fragmented healthcare ecosystem into a connected pathway where every data point delivers impact. With 23 years of trusted solutions and partnerships, the company aims to drive better outcomes and create revenue-generating opportunities for client partners while enhancing security, compliance, and clinical integrity.